Verbelen Hanne, Tjalma Wiebren, Dombrecht Dorien, Gebruers Nick
Department of Rehabilitation Sciences and Physiotherapy (REVAKI-MOVANT), Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium.
Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium.
Arch Physiother. 2021 Mar 29;11(1):8. doi: 10.1186/s40945-021-00103-4.
Breast edema can arise from different etiologies; however, it is mostly seen after breast conserving surgery and/or radiotherapy. Combining breast conserving surgery and radiotherapy can cause damage to the lymphatic system and reactions to surrounding tissues, which can lead to breast edema; hereby, the breast size can increase by more than one cup size. Swelling of the breast is not the only criterion associated with breast edema. Other common criteria found in literature are peau d'orange, heaviness of the breast, skin thickening, breast pain, redness of the skin, hyperpigmented skin pores and a positive pitting sign. Despite the benefits of breast conserving surgery, breast edema can be uncomfortable, and can negatively influence quality of life in suffering patients. In contrast to lymphedema of the arm, which is well known in clinical practice and in research, breast edema is often underestimated and far less explored in literature. Currently, many aspects still need to be reviewed.
This masterclass aims at providing the state of the art of breast edema for all health care workers and researchers involved in the treatment and monitoring of breast cancer patients. It includes current and future perspectives on its diagnosis, longitudinal course and treatment. Furthermore, recommendations for clinical practice and future research are discussed.
It is recommended to closely monitor those patients in whom breast edema symptoms do not decline within 6 months after termination of radiotherapy and provide them with the appropriate therapy. Since evidence concerning the treatment of breast edema is currently lacking, we recommend the complex decongestive therapy (CDT) to the utmost extent, by analogy with the lymphedema treatment of the extremities. This treatment involves skin care, exercise therapy and compression. Additionally, all patients should be informed about the normal course of breast edema development.
A consensus should be reached among clinicians and researchers concerning the definition, assessment methods and best treatment of breast edema. Furthermore, high quality studies are necessary to prove the effectiveness of the CDT for breast edema.
乳腺水肿可由不同病因引起;然而,其多见于保乳手术和/或放疗后。保乳手术与放疗相结合可导致淋巴系统受损及周围组织发生反应,进而引发乳腺水肿;据此,乳房大小可增大超过一个罩杯尺寸。乳房肿胀并非乳腺水肿的唯一相关标准。文献中发现的其他常见标准包括橘皮样皮肤、乳房沉重感、皮肤增厚、乳房疼痛、皮肤发红、皮肤毛孔色素沉着以及凹陷征阳性。尽管保乳手术有诸多益处,但乳腺水肿会给患者带来不适,并对其生活质量产生负面影响。与临床实践和研究中广为人知的手臂淋巴水肿不同,乳腺水肿常被低估,且在文献中的探讨也少得多。目前,许多方面仍有待审视。
本大师班旨在为所有参与乳腺癌患者治疗和监测的医护人员及研究人员提供乳腺水肿的最新情况。内容包括其诊断、病程及治疗的当前和未来观点。此外,还讨论了临床实践建议和未来研究方向。
建议密切监测放疗结束后6个月内乳腺水肿症状未减轻的患者,并为其提供适当治疗。由于目前缺乏关于乳腺水肿治疗的证据,我们极力推荐采用综合消肿治疗(CDT),这是类比肢体淋巴水肿治疗得出的方法。该治疗包括皮肤护理、运动疗法和加压治疗。此外,应告知所有患者乳腺水肿发展的正常过程。
临床医生和研究人员应就乳腺水肿的定义、评估方法和最佳治疗达成共识。此外,需要高质量研究来证明CDT对乳腺水肿的有效性。